Details of the Drug Reposition

General Information of This Drug (ID: DM3L52Q)

Drug Name
Chlorcyclizine   DM3L52Q
Synonyms
1-(4-Chlorobenzhydryl)-4-methylpiperazine; Alergicide; Chlorcycline; Chlorcyclizine [INN:BAN]; Chlorcyclizinum; Chlorcyclizinum [INN-Latin]; Chlorocycline; Chlorocyclizine; Clorciclizina; Clorciclizina [DCIT]; Clorciclizinio [INN-Spanish]; Compound 47-282; Di-Paralene; Di-paralen; Diparalene; HSDB 3217; Histachlorazene; Histantin; Histantine; N-Methyl-N'-(4-chlorobenzhydryl)piperazine; NSC 25246; Perazyl; Piparalene; Trihistan; chlorcyclizine
Therapeutic Class
Antihistamines
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Common cold DIS3MADM CA00 Approved [1]
Allergic rhinitis DIS3U9HN CA08.0 Approved [2]
Cough DIS51FA4 MD12 Approved [3]
------------------------------------------------------------------------------------
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Allergic conjunctivitis DISZ5ZJN 9A60.02 Withdrawn [4]
------------------------------------------------------------------------------------

References

1 Chlorcyclizine hydrochloride poisoning in an infant. Br Med J. 1954 Mar 20;1(4863):687-8.
2 An evaluation of perazil in allergic rhinitis. Ann Allergy. 1950 Sep-Oct;8(5):682-3; passim.
3 Experimental and clinical evaluation of chlorcyclizine as an antitussive. Arzneimittelforschung. 1957 May;7(5):301-4.
4 Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease